# Pharmacological profiling of Gnetum gnemon var. tenerum extracts exhibits antibacterial, antioxidant, cytotoxic and anti-inflammatory activities

**Authors:** Tachpon Techarang, Nateelak Kooltheat, Watcharapong Mitsuwan, Morteza Saki, Chonticha Romyasamit

PMC · DOI: 10.1038/s41598-026-38348-3 · Scientific Reports · 2026-02-03

## TL;DR

This study shows that extracts from Gnetum gnemon var. tenerum have antioxidant, antibacterial, cytotoxic, and anti-inflammatory properties, supporting its traditional use and potential for drug development.

## Contribution

The study identifies specific fractions of Gnetum gnemon var. tenerum with multi-target pharmacological activities and their bioactive compounds through LC–MS profiling.

## Key findings

- Ethyl acetate and n-butanol fractions showed the highest levels of phenolic and flavonoid compounds.
- Chloroform and ethyl acetate fractions exhibited strong antibacterial activity with low MIC values against Acinetobacter baumannii.
- Extracts showed selective cytotoxicity toward cancer cells with minimal impact on normal cells.

## Abstract

This study conducted a comprehensive in vitro pharmacological evaluation of the crude extract and solvent-partitioned fractions of Gnetum gnemon var. tenerum. LC–MS metabolite profiling identified 77 compounds, including flavonoids and phenylethanolamine derivatives, that exhibit the antioxidant, cytotoxic, and anti-inflammatory activities described in this paper. The total phenolic and flavonoid contents (TPC/TFC) were quantified, showed that the ethyl acetate and n-butanol fractions contained the highest levels of these phytochemicals. These fractions exhibited strong antioxidant activity in both ABTS and DPPH assays. The antibacterial activity of the extracts was assessed using disk diffusion, MIC, and MBC assays against five pathogenic bacteria, where the chloroform and ethyl acetate fractions demonstrated the highest potency, with MIC values as low as 0.049 mg/mL against Acinetobacter baumannii. Cytotoxicity testing on human gastrointestinal cancer cell lines (AGS, HT-29) and a normal intestinal epithelial cell line (HIEC-6) showed dose-dependent cytotoxicity toward cancer cells while exerting markedly lower effects on normal cells, suggesting selective action. Anti-inflammatory activity, evaluated by nitric oxide (NO) inhibition in LPS-stimulated RAW264.7 macrophages, revealed that the chloroform and ethyl acetate fractions most effectively suppressed NO production. These findings provide scientific support for the traditional uses of G. gnemon and highlight its extracts as a promising source of bioactive compounds with multi-target pharmacological potential against oxidative stress, bacterial infections, inflammation, and cancer.

## Linked entities

- **Chemicals:** doxorubicin (PubChem CID 31703)
- **Diseases:** cancer (MONDO:0004992)
- **Species:** Acinetobacter baumannii (taxon 470), Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** bacterial infections (MESH:D001424), cancer (MESH:D009369), Cytotoxicity (MESH:D064420), gastrointestinal cancer (MESH:D005770), inflammation (MESH:D007249)
- **Chemicals:** phenylethanolamine (MESH:C523155), ABTS (MESH:C002502), phenolic (-), NO (MESH:D009569), n-butanol (MESH:D020001), chloroform (MESH:D002725), DPPH (MESH:C004931), ethyl acetate (MESH:C007650), flavonoid (MESH:D005419), LPS (MESH:D008070)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Homo sapiens (human, species) [taxon 9606], Gnetum gnemon (species) [taxon 3382]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920789/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920789/full.md

---
Source: https://tomesphere.com/paper/PMC12920789